home / stock / tlc / tlc news

TLC News and Press, Taiwan Liposome Company Ltd.

Stock Information
Company Name: Taiwan Liposome Company Ltd.
Stock Symbol: TLC
Market: NASDAQ
Website: tlcbio.com
Menu
TLC TLC Quote TLC Short TLC News TLC Articles TLC Message Board
Get TLC Alerts

News, Short Squeeze, Breakout and More Instantly...
TLC - Highlights of Dr. David Hunter's Oral Presentation at ACR's Late Breaking Abstracts Session

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
TLC - TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...

TLC - TLC Announces TLC599 Agreement with Endo

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has entered a commercialization agreem...

TLC - TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that detailed results of its TLC599 Phase 2 clinica...
TLC - TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

TAIPEI, Taiwan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company or TLC (Nasdaq: TLC, TWO: 4152, “the Company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, announced today that it has ...

TLC - TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC , a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced financial results for the second quarter ended June 30, 2021 an...

TLC - Short Squeeze Stocks: XELA, NEGG and 3 Other Stocks Experts Think Are Ready to Pop

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short squeezes are what retail investors dream of these days. With their potential for massive gains and popularity on r/WallStreetBets, looking for the next squeeze is a viable, if volatile investment strategy. Investors...
TLC - Taiwan Liposome Company jumps 13%, gives swap transaction details

A clinical-stage specialty pharmaceutical company, Taiwan Liposome Company (TLC) provides stock swap transactions with Woods Investment Company.Woods will issue Series B preferred shares as consideration at NT$100 a share, without adjustment mechanisms for price or share conver...

TLC - WB, OCGN among premarket gainers

Weibo WB +43% on report that Chairman Chao, investor in talks for at least $20B buyout.Bridgeline Digital (BLIN) +35%.BSQUARE (BSQR) +32%.Marin Software (MRIN) +26%.Axcella Health (AXLA) +23%.Odonate Therapeutics (ODT) +21%.Ocugen OCGN +19% Shares extended gains after part...

TLC - TLC Announces Details of Stock Swap Transactions

TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced details of the company...
Next 10